May 22-23, 2013
Welcome to ActoGeniX
ActoGeniX is a biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs; ActoBiotics™.
ActoGeniX’s mission is to develop and commercialize innovative biological therapies, to improve the treatment and well-being of patients with gastrointestinal, immunological and metabolic diseases.
ActoBiotics™ represent a novel concept for oral administration of therapeutic proteins, and are designed to be safer and more effective than injectable biopharmaceuticals. This novel class of biopharmaceuticals has the potential to treat a broad range of severe diseases.
Video: What are ActoBiotics™?
Watch our introduction video on ActoBiotiocs by clicking on the image.